These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 29263709)
1. Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer. Minami S; Ogata Y; Ihara S; Yamamoto S; Komuta K Lung Cancer (Auckl); 2017; 8():249-257. PubMed ID: 29263709 [TBL] [Abstract][Full Text] [Related]
2. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer. Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752 [TBL] [Abstract][Full Text] [Related]
3. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer. Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713 [No Abstract] [Full Text] [Related]
4. Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Shoji F; Takeoka H; Kozuma Y; Toyokawa G; Yamazaki K; Ichiki M; Takeo S Lung Cancer; 2019 Oct; 136():45-51. PubMed ID: 31437663 [TBL] [Abstract][Full Text] [Related]
5. Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region. Wu Y; Yang J; Qiao X; Li Y; Zhao R; Lin T; Li X; Wang M Front Oncol; 2023; 13():1041140. PubMed ID: 37007079 [TBL] [Abstract][Full Text] [Related]
6. The prognostic value of prognostic nutritional index (PNI) and neutrophil to lymphocyte ratio (NLR) for advanced non-small cell lung cancer treated with platinum-based chemotherapeutics. Wang J; Liu Y; Mi X; Shao M; Liu L Ann Palliat Med; 2020 May; 9(3):967-978. PubMed ID: 32389020 [TBL] [Abstract][Full Text] [Related]
7. Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation. Minami S; Ihara S; Kim SH; Yamamoto S; Komuta K World J Oncol; 2018 Feb; 9(1):13-20. PubMed ID: 29581811 [TBL] [Abstract][Full Text] [Related]
8. Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy. Zhang Y; Kong FF; Zhu ZQ; Shan HX BMC Cancer; 2023 Mar; 23(1):225. PubMed ID: 36894927 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients. Zhou T; Zhao Y; Zhao S; Yang Y; Huang Y; Hou X; Zhao H; Zhang L J Cancer; 2019; 10(7):1685-1692. PubMed ID: 31205524 [TBL] [Abstract][Full Text] [Related]
10. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy. Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228 [TBL] [Abstract][Full Text] [Related]
11. Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib. Olmez OF; Bilici A; Gursoy P; Cubukcu E; Sakin A; Korkmaz T; Cil I; Cakar B; Menekse S; Demir T; Acikgoz O; Hamdard J Pulmonology; 2023; 29(6):478-485. PubMed ID: 36564237 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of inflammation-based markers for predicting the prognosis of unresectable pancreatic ductal adenocarcinoma treated with chemotherapy. Asama H; Suzuki R; Takagi T; Sugimoto M; Konno N; Watanabe K; Nakamura J; Kikuchi H; Takasumi M; Sato Y; Irie H; Hikichi T; Ohira H Mol Clin Oncol; 2018 Oct; 9(4):408-414. PubMed ID: 30233794 [TBL] [Abstract][Full Text] [Related]
13. Modified Glasgow Prognostic Score as a Prognostic Factor in Patients with Extensive Disease-Small-Cell Lung Cancer: A Retrospective Study in a Single Institute. Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M; Kanda S; Koizumi T Chemotherapy; 2019; 64(3):129-137. PubMed ID: 31622969 [TBL] [Abstract][Full Text] [Related]
14. Clinical impact of pretreatment prognostic nutritional index (PNI) in small cell lung cancer patients treated with platinum-based chemotherapy. Jin S; Cao S; Xu S; Wang C; Meng Q; Yu Y Clin Respir J; 2018 Sep; 12(9):2433-2440. PubMed ID: 30074685 [TBL] [Abstract][Full Text] [Related]
15. Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer. Tsuchihashi K; Ito M; Moriwaki T; Fukuoka S; Taniguchi H; Takashima A; Kumekawa Y; Kajiwara T; Yamazaki K; Esaki T; Makiyama A; Denda T; Satake H; Suto T; Sugimoto N; Katsumata K; Ishikawa T; Kashiwada T; Oki E; Komatsu Y; Okuyama H; Sakai D; Ueno H; Tamura T; Yamashita K; Kishimoto J; Shimada Y; Baba E Clin Colorectal Cancer; 2018 Dec; 17(4):e687-e697. PubMed ID: 30149986 [TBL] [Abstract][Full Text] [Related]
16. Preoperative prognostic nutritional index is a powerful predictor of prognosis in patients with stage III ovarian cancer. Zhang W; Ye B; Liang W; Ren Y Sci Rep; 2017 Aug; 7(1):9548. PubMed ID: 28842710 [TBL] [Abstract][Full Text] [Related]
17. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A; Eo W; Lee S World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648 [TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of prognostic nutritional index and modified Glasgow prognostic score in advanced lung cancer with targetable mutation. Bilgin B; Kuralay Y; Yucel S J Cancer Res Clin Oncol; 2024 Apr; 150(4):215. PubMed ID: 38668879 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer. Kimura S; D' Andrea D; Soria F; Foerster B; Abufaraj M; Vartolomei MD; Iwata T; Karakiewicz PI; Rink M; Gust KM; Egawa S; Shariat SF Urol Oncol; 2019 Mar; 37(3):179.e19-179.e28. PubMed ID: 30580906 [TBL] [Abstract][Full Text] [Related]
20. Combined systemic immune-inflammatory index and prognostic nutritional index predict outcomes in advanced non-small cell lung cancer patients receiving platinum-doublet chemotherapy. Fan R; Chen Y; Xu G; Pan W; Lv Y; Zhang Z Front Oncol; 2023; 13():996312. PubMed ID: 37077828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]